Download Hallucinogens

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Drug design wikipedia , lookup

Drug discovery wikipedia , lookup

Pharmacokinetics wikipedia , lookup

Pharmacogenomics wikipedia , lookup

Medication wikipedia , lookup

Polysubstance dependence wikipedia , lookup

Serotonin syndrome wikipedia , lookup

Pharmaceutical industry wikipedia , lookup

Prescription costs wikipedia , lookup

Amphetamine wikipedia , lookup

Drug interaction wikipedia , lookup

Pharmacognosy wikipedia , lookup

Neuropsychopharmacology wikipedia , lookup

Neuropharmacology wikipedia , lookup

Stimulant wikipedia , lookup

Psychedelic therapy wikipedia , lookup

Psychopharmacology wikipedia , lookup

Transcript
Hallucinogens
Hallucinogens
• Hallucinogens are substances
that alter sensory processing in
the brain,
causing perceptual disturbances,
changes in thought processing,
and depersonalization
Modern Day History of
Hallucinogens
Vietnam War
Timothy Leary
Harvard professor
The Psychedelic Experience
The Nature of Hallucinogens
• Many drugs can exert hallucinogenic effects
related to neurotransmitters:
Serotonin: LSD, psilocybin, DMT
Norepinephrine: amphetamine related,
mescaline, MDMA
Acetylcholine: atropine, scopolamine
Dissociative anesthetics: PCP, ketamine
Names for Hallucinogens
Psychedelic
Psychotogenic
Psychotomimetic
Sensory and Psychological Effects
Altered perception.
- Synesthesia: blending of the
senses. Perceptual changes.
Self-reflection
- “Make conscious the
unconscious”
Loss of identity and cosmic
merging
- “Mystical-spiritual aspect of the
drug experience”
Aldous Huxley: Doors of
Perception.
LSD class drugs
LSD, mescaline,
psilocybin, DMT, bufotenine
Primarily act on Serotonin receptors
Frontal cortex and limbic system
Also act on raphe nucleus which functions
to filter incoming sensory stimuli
Disrupts the sorting process
Flood of sensations and perceptions
LSD-class Hallucinogens
LSD Types of Agents
These drugs cause
predominantly
psychedelic effects.
Of high school seniors
sampled:
- 1999—12.2% had used
LSD sometime during life
- 2002—8.4% had used
LSD sometime during life
Albert Hofmann and LSD model
LSD Physical Effects
LSD Types of Agents
Physiological effects:
- Massive increase in neural
activity in some brain regions
- Activates sympathetic
nervous system (rise in body
temperature, heart rate, and
blood pressure)
- Parasympathetic nervous
system (increase in salivation
and nausea)
LSD Timeline
• About half of the
substance is cleared from
the body within 3 hours,
and more than 90% is
excreted within 24 hours.
Effects of this
hallucinogen can last 2–
12 hours.
Tolerance to the effects of
LSD develops very
quickly.
Psilocybin
• Psilocybin—its principal source is the
Psilocybe mexicana mushroom.
It is not very common on the street.
Hallucinogenic effects produced are quite
similar to LSD.
Cross-tolerance among psilocybin, LSD,
mescaline.
Stimulates the autonomic nervous system,
dilates the pupils, increases the body
temperature
Psilocybe Mushrooms
Small brown
mushrooms that stain
blue to the touch
Illicit cultivation but
also foraged from
temperate climates
Psilocybe Mushrooms:
Religious Use
Religious use continues in Oaxaca, Mexico
Dimethyltryptamine (DMT)
Dimethyltryptamine (DMT)
- A short-acting hallucinogen
- Found in seeds of certain leguminous trees
and prepared synthetically.
- It is inhaled and similar action as psilocybin.
- High doses can be quite intoxicating.
- Can also cause unpleasant reactions/\.
DMT…it’s as common as
crabgrass…
“Canary” grass; Phalaris aquatica, P.
arundinacea, P. canariensis, P. tuberosa
Desmanthus illinoensis; Prairie
Bundleflower
Many other sources; mostly S. America.
Phalaris (DMT source)
Desmanthus illinoesis (DMT Source)
Bufo Frogs…
Contains bufontinin but intoxication
primarily from 5-Meo-DMT
The toad is NOT licked but glands are
milked for poison
Amphetamine Class
Mescaline
Synthetic amphetamine derivatives (DOM,
MDA, MDMA)
Act on dopamine and serotonin
Amphetamine Hallucinogens
Drugs are chemically related to amphetamines.
They have varying degrees of hallucinogenic
and CNS stimulant effects.
- Release serotonin are dominated by their
hallucinogenic action
- Release dopamine are dominated by their
stimulant effects
Amphetamine Hallucinogens
Mescaline
“Designer” amphetamines
3,4 Methylenedioxyamphetamine (MDA)
Methylenedioxymethamphetamine
(MDMA, Ecstasy)
Ephedra of the US
E. trifurca, E. viridis, E. torreyana, E. nevadensis and E.
californica
100 gm dried ephedra could contain anywhere
from 0 to 2.6 gm of ephedrine.
Ephedra grows in the deserts
of the Southwest
Mescaline
- Mescaline is the most active drug in
peyote cactus; it induces
intensified perception of colors and
euphoria
- Effects include dilation of the
pupils, increase in body
temperature, anxiety, visual
hallucinations, and alteration of
body image, vomiting, muscular
relaxation.
Very high doses may cause death.
- Street samples are rarely
authentic.
Peyote
Lophophoria williamsii
contains 1.5% mescaline (b3,4,5-trimethoxyphenethylamine)
3mg/kg potent intoxication
Up to 8 to 10 hour duration
Continued religious use in
North America
Other cacti used in South
America and also…
Harvesting Peyote
Natural Range of Peyote
The Peyote Ceremony
Stewart OC. Peyote Religion. Norman, OK:
University of Oklahoma Press, 1987.
Aberle DF. The Peyote Religion Among the Navaho.
Chicago, IL: Aldine Publishing Co., 1966.
MDMA (‘Ecstasy’)
Psychostimulants
The most common psychostimulants (cocaine,
MDMA and amphetamine) act on the synapse
to increase the activity of dopamine,
noradrenaline and serotonin.
Cocaine
blocks
pre-synaptic
reuptake
MDMA (‘Ecstasy’)
A synthetic amphetamine derivative, usually sold as small
tablets or capsules
Many tablets sold as ecstasy also contain other chemicals
including: ketamine, GHB, amphetamine, caffeine.
A recent study (Baggott et al 2000) found that:



63% contained MDMA
29% contained other substances (e.g. caffeine,
psuedoephedrine)
8% contained no MDMA
MDMA (‘Ecstasy’): Effects
Immediate sought after-effects, 4-6 hours in duration

euphoria, increased confidence, increased perception
of closeness to others, visual hallucinations
Negative effects

jaw clenching, anxiety, paranoia, insomnia, dry mouth,
increased body temperature
Party drug culture
High levels of activity: hydration and
hyperthermia
Poly-drug use, illicit and misuse of
prescribed substances:


Viagra used primarily within the gay community
Anti-depressants and benzodiazepines thought to
increase the ‘high’ or relieve the ‘come down’
associated with party drug use
Risks of Ecstasy
Toxicity: MDMA overdose is rare

associated with intense sympathomimetic responses and
active hallucinations as well as thermoregulatory, neurologic,
cardiovascular, hepatic and electrolyte disturbances (Gowing
et al 2002).
Risks of adulterants
Dependence syndrome (occasionally)
Some evidence of cognitive impairment as a result of long term
use (Kalant, 2001)
Association between long-term MDMA use and emotional
disturbance (depression).
Anticholinergics
Attach to Ach receptors and act as
antagonists
Found in Belladonna, Nightshade,
Jimsonweed and Mandrake plants
Ach Antagonists
Plants containing scopolamine
Low doses produce amnesia, fatigue,
mental confusion, dreamless sleep and loss
of attention
High doses: Hallucinations, paralysis of
respiratory system, coma, and death.
Side Effects: increase in sympathetic activity
Hot as a hare, dry as a bone, red as a beet,
and mad as a hen
Datura stramonium
Leaves typically cut and smoked
Contains atropine, scopalomine
Ancient ceremonial use in the U.S.
Occasional report of death by
ingestion of root
Many other sources for atropine
and scopalomine
Member of Nightshade family
“Jimson weed”
Dissociative Drugs
Dissociative Drugs
PCP (phencyclidine)
Ketamine
Dextromethorphan
• Phencyclidine (PCP)
It was developed as an intravenous anesthetic,
but found to have serious adverse side effects.
It differs from the other traditional hallucinogens.
It is a general anesthetic in high doses.
It causes incredible strength and extreme violent
behavior.
Management of the severe psychological reactions
requires drug therapy.
PCP physiological effects
- Hallucinogenic effects, stimulation, depression,
anesthesia, analgesia
- Large doses can cause coma, convulsions,
and death.
PCP psychological effects
- Feelings of strength, power, invulnerability;
perceptual distortions, paranoia, violence,
Potential for psychotic break.
Ketamine (“Special K”)
Anesthetic developed to replace PCP,
manufactured by Pfizer
Used in human and veterinary medicine
Injected or dried and snorted
Feelings of floating, or sometimes terrifying “bad
trip” called “K hole”
“Vitamin K”
“K”
“Bump”
DXM (dextromethorphan)
Cough suppressant
(Also used to boost effects of analgesics
for severe pain)
Typical dose 15-30 mg. for cough
4 or more ounces may cause distorted visual
perceptions, similar effects to PCP and
Ketamine
“Robo”
Internet groups to discuss “Robo-ing”
Statistics on Use
National Survey on Drug Use and
Health (2004 & 2005)
Monitoring the Future (National
Survey)
(2005)
Drug Abuse Warning Network
(DAWN)
NSDUH Hallucinogen Statistics
Percentages of Past Year Hallucinogen Use among Persons
Aged 12 or Older, by Age Group: 2004 and 2005
Monitoring the Future Hallucinogens 2005
8th
10th
12th
Psychedelics
2.4
4.0
5.5
LSD
1.2
1.5
1.8
Others
2.0
3.5
5.0
Hallucinogens in ER Visits, 2005
Drug
Drug-Related ER
Visits DAWN
Hospitals
Cocaine
448, 481
Heroin
164, 572
Ketamine
275
LSD
1,864
PCP
7,535
Misc. hallucinogens
3,792
AAPCC Annual Report 2005
Substance
Number of human exposures reported to
US Poison Control Centers
Hallucinogenic mushrooms
849
Muscarine mushrooms
19
Hallucinogenic plants
355
Solanine plants (nightshade family)
1,166
Ketamine
161
Dextromethorphan (APA/ASA)
67,038.00
Hallucinogens (general, various)
1,924
Mescaline/peyote
102
PCP
662
2005 Annual Report of the American Association of Poison Control Centers’ National
Poisoning and Exposure Database. Clinical Toxicology, 44:803-932, 2006